Economic evaluation of diagnostic platforms for T790M detection in post EGFR-TKI NSCLC in Brazil

Authors :: G. Montenegro
Rosangela Caetano
M. Custodio
Carlos Gil Ferreira
Luciene Schluckebier
Source :: Journal of Clinical Oncology. 36:e21159-e21159
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e21159Background: Around 50% of all acquired resistance to first or second-generation EGFR-TKIs during the treatment of NSCLC can be attributed to T790M mutation. Clinical trial data demonstrated s...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
food and beverages
respiratory tract diseases
Clinical trial
T790M
Egfr tki
Acquired resistance
Internal medicine
Mutation (genetic algorithm)
Economic evaluation
medicine
business

Full Text Access

Tools